Implication of Cytotoxic Helicobacter pylori Infection in Autoimmune Diabetes

Table 2

Distribution of CagA status among the three study groups.

	Autoimmune diabetes		Nonautoimmune diabetes
	Type 1	LADA	Type 2
	()	()	()
Hp negative	58 (55%)	112 (48%)	80 (51%)
Hp positive, CagA negative	26 (25%)	73 (31%)	57 (37%)
Hp positive, CagA positive	21 (20%)	49 (21%)	19 (12%)
CagA prevalence in Hp positive patients	45%	40%	25%

Hp positive, autoimmune versus nonautoimmune diabetes: = 0.0055; .
CagA positive, autoimmune versus nonautoimmune diabetes: = 1.556; .
CagA positive/Hp positive, type 1 versus type 2 diabetes: = 5.125; .
CagA positive/Hp positive, LADA versus type 2 diabetes: = 4.775; .